Endothelin receptor antagonist bosentan improves the dermal sclerosis in a patient with systemic sclerosis

被引：3
|
作者：
Nishibu, Akiko [1 ,2 ]
Sakai, Erika [1 ]
Oyama, Noritaka [1 ]
Yamamoto, Toshiyuki [1 ]
机构：
[1] Fukushima Med Univ, Dept Dermatol, Fukushima, Japan
[2] Kanazawa Med Univ, Dept Dermatol, Kanazawa, Ishikawa, Japan
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2012年 / 53卷 / 02期
关键词：
bosentan; endothelin; systemic sclerosis; DIGITAL ULCERS;
D O I：
10.1111/j.1440-0960.2010.00719.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
We report a case of systemic sclerosis with interstitial pneumonia and severe pulmonary hypertension treated with bosentan, an endothelin receptor antagonist. Within a short period of administration of the bosentan the skin sclerosis improved.
引用
收藏
页码：E32 / E33
页数：2
相关论文
共 50 条
  • [21] Clinical pharmacology of bosentan, a dual endothelin receptor antagonist
    Dingemanse, J
    van Giersbergen, PLM
    CLINICAL PHARMACOKINETICS, 2004, 43 (15) : 1089 - 1115
  • [22] Improved Procedure for the Preparation of Bosentan, an Endothelin Receptor Antagonist
    Manne, Satyanarayana Reddy
    Srinivasan, Thirumalai Rajan
    Sajja, Eswaraiah
    Rebelli, Pradeep
    Nadendla, Hareesh Kumar
    Bairy, Kondal Reddy
    Ghojala, Venkat Reddy
    Chepyala, Kista Reddy
    ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL, 2013, 45 (06) : 510 - 514
  • [23] Evaluation of the Highly Selective Endothelin a Receptor Antagonist Zibotentan in Systemic Sclerosis Associated Chronic Kidney Disease
    Stern, Edward
    Host, Lauren
    Escott, K. Jane
    Gilmour, Peter
    Wanjiku, Ivy
    Ochiel, Rachel
    Burns, Aine
    Unwin, Robert
    Ong, Voon
    Denton, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [24] Clinical Pharmacology of Bosentan, a Dual Endothelin Receptor Antagonist
    Jasper Dingemanse
    Paul L. M. van Giersbergen
    Clinical Pharmacokinetics, 2004, 43 : 1089 - 1115
  • [25] An Alternate Synthesis of Bosentan Monohydrate, an Endothelin Receptor Antagonist
    Pradeep, Rebelli
    Rao, Yerrabelly Jayaprakash
    Kumari, Yalamanchili Bharathi
    Subbanarsimulu, Porala
    Reddy, Ghojala Venkat
    Reddy, Bairy Kondal
    SYNLETT, 2014, 25 (02) : 265 - 269
  • [26] New Approaches to Endothelin Receptor Antagonist-Bosentan
    Rebelli, Pradeep
    Yerrabelly, Jayaprakash Rao
    Yalamanchili, Bharathi Kumari
    Kommera, Rajashekar
    Ghojala, Venkat Reddy
    Bairy, Kondal Reddy
    LETTERS IN ORGANIC CHEMISTRY, 2013, 10 (05) : 364 - 368
  • [27] Bosentan for digital ulcers in patients with systemic sclerosis
    Nagai, Yayoi
    Hasegawa, Michiko
    Hattori, Tomoyasu
    Okada, Etsuko
    Tago, Osamu
    Ishikawa, Osamu
    JOURNAL OF DERMATOLOGY, 2012, 39 (01): : 48 - 51
  • [28] Bosentan therapy for cutaneous fibrosis in systemic sclerosis
    Alegre-Sancho, J. J.
    Roman-Ivorra, J. A.
    Chalmeta-Verdejo, C.
    Fernandez-Carballido, C.
    Fernandez-Llanio, N.
    Ivorra-Cortes, J.
    Hortal-Alonso, R.
    Alcaniz-Escandell, C.
    Abad-Franch, L.
    Valls-Pascual, E.
    Senabre-Gallego, J. M.
    Munoz-Gil, S.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S89 - S96
  • [29] Positive findings for bosentan in systemic sclerosis patients
    不详
    DRUG NEWS & PERSPECTIVES, 2005, 18 (06) : 411 - 411
  • [30] Endothelin receptor antagonist bosentan improves microcirculatory blood flow in splanchnic organs in septic shock
    Krejci, V
    Hiltebrand, LB
    Erni, D
    Sigurdsson, GH
    CRITICAL CARE MEDICINE, 2003, 31 (01) : 203 - 210
12345